The International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress
London, UK 09 July 2022 - 13 July 2022
Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
16 Aug 2022
byRoshini Claire Anthony
A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.
Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
16 Aug 2022
VTE prevention in pregnancy: Does heparin dose matter?
02 Aug 2022
byRoshini Claire Anthony
In pregnant women with a history of venous thromboembolism (VTE), receipt of low-molecular-weight heparin (LMWH) at either a weight-adjusted intermediate-dose or fixed low-dose during the antepartum and postpartum periods results in similar VTE incidence, according to findings of the Highlow study. However, there was a numerically lower incidence of VTE during the postpartum period with intermediate-dose LMWH.